1 – 10 of 24
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum
(
- Contribution to journal › Article
-
Mark
Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1)
(
- Contribution to journal › Article
- 2020
-
Mark
[18F]Flortaucipir distinguishes Alzheimer’s disease from progressive supranuclear palsy pathology in a mixed-pathology case
(
- Contribution to journal › Letter
- 2019
-
Mark
TCF4 (E2-2) harbors tumor suppressive functions in SHH medulloblastoma
(
- Contribution to journal › Article
-
Mark
Novel tau fragments in cerebrospinal fluid : relation to tangle pathology and cognitive decline in Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease
(
- Contribution to journal › Article
- 2018
-
Mark
Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson’s disease
(
- Contribution to journal › Article
-
Mark
Sex-specific genetic predictors of Alzheimer’s disease biomarkers
(
- Contribution to journal › Article
- 2017
-
Mark
Genome-wide association study identifies four novel loci associated with Alzheimer’s endophenotypes and disease modifiers
(
- Contribution to journal › Article
-
Mark
Tau neuropathology correlates with FDG-PET, but not AV-1451-PET, in progressive supranuclear palsy
(
- Contribution to journal › Article